Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?

Bibliographic Details
Main Authors: Luis Eduardo Miani Gomes, Francesca Aparecida Ramos da Silva, Lívia Bitencourt Pascoal, Renato Lazarin Ricci, Guilherme Nogueira, Michel Gardere Camargo, Maria de Lourdes Setsuko Ayrizono, João José Fagundes, Raquel Franco Leal
Format: Article
Language:English
Published: Faculdade de Medicina / USP
Series:Clinics
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322019000100405&lng=en&tlng=en

Similar Items